The Nanotechnology Drug Delivery Market is Predict to reach USD 153 Billion by 2030, at a CAGR of 8.7%
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Nanotechnology Drug Delivery Market Growth, Trends and Report Highlights
According to a new report, published by KBV research, The Global Nanotechnology Drug Delivery Market size is expected to reach $153.0 billion by 2030, rising at a market growth of 8.7% CAGR during the forecast period.
The Polymer-Based Nanomedicine segment is leading the Global Nanotechnology Drug Delivery Market, by Formulation in 2022; thereby, achieving a market value of $53.3 Billion by 2030. Polymer-based nanocarriers offer a wide range of tunable properties, including size, surface charge, and degradation kinetics. This versatility allows researchers to customize nanocarriers for specific therapeutic applications, addressing the diverse needs of different drugs and diseases. These factors will boost the demand in the segment.
The Infectious Diseases segment is experiencing a CAGR of 8.2% during (2023 - 2030). Nanotechnology has enabled the development of novel antimicrobial agents to combat bacterial and fungal infections. Nanoparticles, such as silver nanoparticles and nanocomposites, exhibit potent antimicrobial properties. These materials can formulate topical creams, wound dressings, and implant coatings with enhanced antibacterial efficacy. Thus, the segment will witness enhanced growth in the coming years.
Full Report: https://www.kbvresearch.com/nanotechnology-drug-delivery-market/
The North America region dominated the Global Nanotechnology Drug Delivery Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $66.5 Billion by 2030. The Europe region is poised to grow a CAGR of 8.5% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 9.6% during (2023 - 2030).
List of Key Companies Profiled
- AbbVie, Inc.
- Pfizer Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Amgen, Inc.
- Merck KGaA
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
Nanotechnology Drug Delivery Market Report Segmentation
By Formulation
- Polymer-Based Nanomedicine
- Lipid-Based Nanomedicine
- Nanocrystals
- Others
By Application
- Oncology & Hematology
- Infectious Diseases
- Orthopedics
- Neurology
- Immunology
- Urology
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Related Reports:
North America Nanotechnology Drug Delivery Market Size, 2030
- January-2024
- 116 Pages
LAMEA Nanotechnology Drug Delivery Market Size, Share 2030
- January-2024
- 119 Pages
Europe Nanotechnology Drug Delivery Market Size, Share, 2030
- January-2024
- 119 Pages
Asia Pacific Nanotechnology Drug Delivery Market Size, 2030
- January-2024
- 119 Pages